2009
DOI: 10.1590/s0482-50042009000100007
|View full text |Cite
|
Sign up to set email alerts
|

Retinite por citomegalovirus (CMV) após terapia imunossupressora para vasculite leucocitoclástica

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
(37 reference statements)
0
1
0
Order By: Relevance
“…This persistent nature of HCMV infection facilitates the use of molecular and immunological diagnostic tools. It also allows the molecular and epidemiological profiling of virus isolates from individuals with risk factors for infection, such as immunosuppression and living in an underdeveloped country where the HCMV seroprevalence is elevated [9][10][11][12][13] . Molecular analyses by restriction fragment length polymorphism (RFLP) and sequencing of the glycoprotein B (gB)-encoding region of the HCMV viral envelop are used as basic tools for genotypic classification of the virus and the association between genotypes and immunodeficient patient categories as assessed by clinicians [14][15][16][17][18][19][20][21][22][23][24] .…”
Section: Introductionmentioning
confidence: 99%
“…This persistent nature of HCMV infection facilitates the use of molecular and immunological diagnostic tools. It also allows the molecular and epidemiological profiling of virus isolates from individuals with risk factors for infection, such as immunosuppression and living in an underdeveloped country where the HCMV seroprevalence is elevated [9][10][11][12][13] . Molecular analyses by restriction fragment length polymorphism (RFLP) and sequencing of the glycoprotein B (gB)-encoding region of the HCMV viral envelop are used as basic tools for genotypic classification of the virus and the association between genotypes and immunodeficient patient categories as assessed by clinicians [14][15][16][17][18][19][20][21][22][23][24] .…”
Section: Introductionmentioning
confidence: 99%